Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for Uremic Pruritis in Hemodialysis Patients
NCT05341843Phase 2Completed
- Sponsor
- Alexandria University
- Start
- May 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in uremic pruritus comparing Sertraline with Placebo (2 arms). Primary endpoint: Change in uremic pruritus intensity at 8 weeks. Started May 2022; status: completed.
02
Drugs
sertraline
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT05341843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05341843.